Health funding

Phantom GI is developing a novel device, PercStoma, designed to create an ostomy using a needle puncture and local anesthesia, bypassing the need for invasive abdominal surgery. This technology targets patients with bowel obstruction who are considered inoperable with conventional methods, potentially reducing risks and costs associated with traditional surgical procedures.

Yazen is a Swedish health startup offering a weight-loss program centered around popular weight-loss drugs. The company is experiencing steady growth and has secured funding to support its operations for the next few years. This round highlights investor interest in companies capitalizing on the trend of weight-loss drugs.

A startup founded by a Nobel Prize winner has raised $350 million. However, the company is now facing funding challenges for its cancer programs. The article does not provide further details on the company's specific focus or the implications of the funding shortfall.

Vitalize is a company focused on addressing hospital staffing shortages. The company has raised $31 million to tackle this critical issue within the healthcare sector.

This startup allows personal trainers to offer labs, peptides, and hormone replacement therapy (HRT) to their clients. The company has raised $7 million in funding.

Absci is a drug discovery company that uses AI to develop new medicines. They are focused on automating the drug manufacturing process. This funding round will help them advance their AI-powered drug discovery platform.

WhiteLab Genomics is developing AI-powered solutions for medicine design. The company aims to accelerate the discovery and development of new therapies. This funding will support their ongoing research and development efforts.

Primerry is a paediatric healthcare brand developing everyday health products for children aged two to 14 years. The company aims to provide trustworthy, clean formulations with unique delivery formats that children will enjoy. They plan to use their recent pre-seed funding to expand their product range and distribution network across India.

XLerateHealth is a commercialization platform that helps universities, biotech hubs, health systems, and other organizations bring early-stage healthcare and life sciences discoveries to market. They plan to use the NIH grant to expand their software architecture, curriculum, AI tools, and expert marketplace. The platform is designed for institutional partners to manage commercialization programs or license their software.

Breye Therapeutics is developing oral therapies for the early treatment of retinal diseases. This funding will advance their pipeline of novel treatments. The company aims to provide more accessible and convenient options for patients suffering from conditions like age-related macular degeneration and diabetic retinopathy.

Omnio is developing a plasminogen-based therapy for chronic wounds. This funding will advance their therapy for hard-to-heal wounds. The company is based in Sweden.

Aptadir Therapeutics is developing a new class of RNA inhibitor-based therapeutics called DNMTs Interacting RNAs (DiRs) to address genetic disorders and oncology. Their platform aims to reactivate silenced genes and restore normal biological functions, potentially offering a way to treat previously irreversible genetic diseases. This seed round will advance their lead candidate for Fragile X Syndrome towards clinical development.

Carebot is a Czech startup developing AI-powered medical scans. The company has raised a record 36 million Czech crowns to further develop its technology and expand its reach.

Vytalyou is a longevity healthcare startup that has raised ₹9 Crore in a Pre-Series A round. The company plans to use the funds to open two new clinics in Mumbai.

Aignosis is a healthtech startup that has developed AI-assisted autism and developmental screening technology. The company aims to make autism screening more accessible across India's healthcare ecosystem, working with both public and private settings. This seed funding will be used to scale their technology and expand its reach.

Lumin is a Wauwatosa-based biotech startup developing a blood test to commercialize its technology. The company has raised $1.5 million to advance its product development and market entry.

Ai3Bio has launched with a $48 million Series A funding round. The company aims to reset the immune system, suggesting a focus on novel therapeutic approaches for immune-related diseases.

Blue Health Intelligence is a preventive HealthTech company based in Amsterdam. The company focuses on expanding its innovative health solutions across Europe, aiming to improve health outcomes through technology.

ADARx is a startup focused on siRNA technology. The company has successfully raised $446.3 million through an IPO, indicating significant investor confidence in its potential within the biotechnology sector.

Precision Neuroscience is developing a brain-computer interface (BCI) called Layer 7, an electrode array that records and stimulates the brain to turn neural signals into digital commands. The company aims to use its recent $250 million Series D funding to advance its BCI technology through FDA review and build commercialization infrastructure. This funding round, co-led by Pershing Square and the Ackman Oxman Institute, brings the company's total funding to $430 million.

Rio Health is a pharmacy-focused quick commerce startup that delivers medicines and healthcare essentials across Delhi NCR in 20-30 minutes. They are using AI to identify medicines from prescription photos and have a network of dark stores. The company aims to reach Rs 150 crore in annual recurring revenue over the next 9-12 months.

Betterhood is a preventive pain care startup that has raised Rs 11.5 crore in a seed funding round. The company offers products like posture and ergonomic supports, orthotic soft goods, and pain relief items, alongside an education platform and a community for physiotherapists. The funding will be used for product expansion, distribution, community building, and scaling content initiatives.

Enveda is an AI drug discovery startup that has raised $311 million, reaching a $2 billion valuation. The company leverages AI to accelerate the drug discovery process.

UltraSight is an Israeli medtech startup that has developed an AI-based platform enabling trained medical staff to perform echocardiograms. The platform aims to address the shortage of cardiac imaging specialists by allowing hospitals to expand access to cardiac imaging without relying solely on specialized sonographers. This funding will support the expansion of its commercial operations and implementation within U.S. healthcare systems.

ViferaXS is a German biotech company developing peptide-based cancer immunotherapies. They are advancing a treatment for chronic lymphocytic leukemia (CLL) into a Phase 2 trial. This funding will support testing the therapy's efficacy in a randomized study.

Kinoxis Therapeutics is a biotech company developing drugs for agitation and pain associated with dementia. The company is a spinout from Sydney University and is now based in Melbourne. This funding will support clinical trials for their drug candidates, KNX100 and KNX101, with results expected in 2027.

Octin Health is developing a novel approach to aortic arch surgery. The company has raised $2.5 million to advance its technology, which aims to provide a less invasive and more effective solution for patients requiring this complex procedure.

Novadip Biosciences is a Belgian late-stage clinical biotech company specializing in regenerative medicine. They have developed a proprietary platform using adipose-derived stem cells to create tissue for healing bone defects and fractures. This funding will support their pivotal Phase 3 clinical trial for NVD003 and preparation for regulatory submission in the United States.

MozartAI is a healthtech automation company that has raised $10 million in seed funding. The company aims to bring its automation solutions to the Mexican market, potentially improving efficiency and accessibility within the healthcare sector.

Disha is a vernacular AI health coaching platform offering personalized diet, fitness, and chronic-care support across 15 conditions. The platform operates in Hindi, English, and Hinglish, providing automated coaching. This Series A funding will be used for working capital, proprietary AI model development, and business expansion.

AbTx is a French biotechnology startup founded in 2024, developing a new generation of antibody-drug conjugates (ADCs) for solid tumors. Their patented Therano-Stick platform uses enzymatic bio-conjugation to create miniaturized ADCs called fragment drug conjugates (FDCs). This seed round aims to validate their novel platform in the competitive ADC field.

Piomic, a Swiss medtech startup spun out of ETH Zurich, develops physical stimulation therapies for deep tissue regeneration. Their lead product, the COMS One Therapy System, is a portable, non-invasive device for treating non-healing wounds. This $25 million growth round will fund clinical trials, US market approval filing, and expansion into new applications.

Penelope Health is a real-time provider and payer policy intelligence platform that aims to bring administrative efficiency to navigating payer requirements in healthcare. They convert complex data into a single infrastructure layer for healthcare companies to check coverage requirements and compare policies across payers. This funding will support the creation of new products to streamline these processes.

Aseptuva is a Swiss-UK Medtech startup developing a targeted Far-UVC disinfection technology to prevent hospital-acquired infections, particularly bloodstream infections associated with intravenous catheters. Their technology aims to reduce infection risk and antibiotic reliance by disinfecting at the catheter-entry site. The company is focused on preventing deaths, shortening hospital stays, and reducing healthcare costs.

Phosphoenix is an Amsterdam-based MedTech startup developing a neuroprosthetic system for people with profound blindness. Their system uses a proprietary Fountain Probe with over 1,000 microelectrodes to directly stimulate the brain's visual pathway, bypassing damage to the eyes. This €1.3 million financing round will support preparations for their first-in-human clinical study and further development of their neurostimulation system.

Wysa is an AI-powered mental health chatbot that provides emotional support and therapeutic exercises. The company aims to make mental wellness accessible and affordable for everyone. This funding will help Wysa expand its services and reach more users globally.

Eterna Regeneratives is a London-based startup developing a biomaterials platform to regenerate human tooth enamel. Their patented material, derived from keratin in sheep's wool and human hair, can be incorporated into toothpaste for enduring enamel repair. The company is targeting the global oral care market with its innovative approach.

TRUE ARTIS is an integrated Indian aesthetic healthcare and surgical platform offering procedures across facial aesthetics, breast surgery, body contouring, and hair restoration. The company aims to build a new category in aesthetic healthcare by focusing on clinical care, patient safety, transparency, and patient experience. This seed funding will be used to expand operations in Delhi NCR, strengthen capabilities, and develop technology.

Waspito is a Cameroonian e-health startup that connects users with medical doctors via instant video consultations from their smartphones. It also provides mobile laboratory services, allowing lab technicians to collect samples from users' homes and deliver results digitally.

Nara Health is a Chicago-based health insurance startup that aims to provide innovative health insurance solutions. The company focuses on improving access to healthcare for individuals and families, making it easier for them to navigate their health insurance options. This funding round will help Nara Health expand its offerings and reach more customers.

Aware Health was a company focused on making preventive health a part of everyday life through whole-body MRI and recurring blood diagnostics. The company aimed to build healthier societies and more effective healthcare systems. It has been acquired by Aeon, a European company in the preventive health space.

Elita is a canine health startup focused on preventative care, offering genetic banking, at-home tests, and 24/7 telehealth services. They are developing technology called Blueprint to track a dog's health over time. The company aims to make preventative care more accessible and improve the standard of care for dogs.

A new cancer biotech company has been launched by the former CEO of Mural Oncology. The company has secured $225 million in venture capital funding to advance its cancer research and development efforts.

Deep Connection Innovation Pvt Ltd is a pediatric neurodevelopment startup using AI-native infrastructure to detect and manage developmental delays and disorders in children. They aim to shift the detection window from age 5 to 1.5 years, believing early intervention during peak brain neuroplasticity is crucial for better long-term outcomes. The company operates a hybrid model combining a digital AI platform with physical child development centers, with its flagship 'FitQuest' program designed for schools, homes, and community settings.

Absci Corporation is a biotechnology company developing ABS-201, a drug for pattern hair loss and endometriosis. The company announced positive early clinical trial data for ABS-201, showing it was well-tolerated and had a long-lasting presence in the body. This news coincided with a $100 million stock offering to fund further development.

Fertally is a Wexford-based fertility tech startup that uses individualised algorithms built from wearable data, indexed against their research database, and shared with clinicians to personalize fertility care. They are planning a €500k funding round later this year to improve upon traditional fertility treatments that rely on population averages.

iPremom is a health technology company that provides a platform for pregnancy tracking and related services. It targets expectant mothers looking for tools to monitor their pregnancy journey. The recent €15M seed funding will help enhance their offerings and expand their market reach.